|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 263/52 | (2006.01) |
| C07D 498/00 | (2006.01) | ||
| C07D 419/14 | (2006.01) |
| (11) | Number of the document | 2721016 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12814591.9 |
| Date of filing the European patent application | 2012-06-15 | |
| (97) | Date of publication of the European application | 2014-04-23 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-06 |
| (46) | Date of publication of the claims translation | 2016-07-25 |
| (86) | Number | PCT/US2012/042622 |
| Date | 2012-06-15 |
| (87) | Number | WO 2013/012500 |
| Date | 2013-01-24 |
| (30) | Number | Date | Country code |
| 201161498110 P | 2011-06-17 | US |
| (72) |
BROOKS, Carl, US
CHEUNG, Mui, US
EIDAM, Hilary, Schenck, US
GOODMAN, Krista, B., US
HAMMOND, Marlys, US
HILFIKER, Mark, A., US
HOANG, Tram, H., US
PATTERSON, Jaclyn, R., US
STOY, Patrick, US
YE, Guosen, US
|
| (73) |
GlaxoSmithKline Intellectual Property (No. 2) Limited,
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | TRPV4 antagonistai |
| TRPV4 ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 14 | 289.00 EUR |
| 2026-06-15 |